Recently, FSTL3 has been shown to regulate numerous BP such as cellular differentiation, aging, obesity development, atherosclerosis progression, and tumor progression (Hayette et al. 1998; Sidis et al. 2002, 2005). The gene discussed is FSTL3; the disease is obesity due to melanocortin 4 receptor deficiency.